{"content":"<li class=\"n-box-item date-title\" data-end=\"1356411599\" data-start=\"1356325200\" data-txt=\"Wednesday, December 18, 2019\">Monday, December 24, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"735001\" data-ts=\"1356379054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/735001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 2:30 p.m.: TVIX +3.6%. UVXY +3.1%. VXX +1.9%. SE +1.6%. ALXA...</a></h4><b>After-hours top gainers, as of 2:30 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/TVIX\" title=\"VelocityShares Daily 2x VIX Short-Term ETN\">TVIX</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/UVXY\" title=\"ProShares Ultra VIX Short-Term Futures ETF\">UVXY</a> <font color=\"green\">+3.1%</font>. <a href=\"https://seekingalpha.com/symbol/VXX\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"green\">+1.9%</font>. <a href=\"https://seekingalpha.com/symbol/SE\" title=\"Sea Ltd\">SE</a> <font color=\"green\">+1.6%</font>. <a href=\"https://seekingalpha.com/symbol/ALXA\" title=\"Alexza Pharmaceuticals, Inc.\">ALXA</a> <font color=\"green\">+1.6%</font>. <br><b>After-hours top losers:</b> <a href=\"https://seekingalpha.com/symbol/UGAZ\" title=\"VelocityShares 3x Long Natural Gas ETN\">UGAZ</a> <font color=\"red\">-2.1%</font>. <a href=\"https://seekingalpha.com/symbol/XIV\" title=\"VelocityShares Daily Inverse VIX Short-Term ETN\">XIV</a> <font color=\"red\">-1.7%</font>. <a href=\"https://seekingalpha.com/symbol/SVXY\" title=\"ProShares Short VIX Short-Term Futures ETF\">SVXY</a> <font color=\"red\">-1.7%</font>. <a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> <font color=\"red\">-1.6%</font>. <a href=\"https://seekingalpha.com/symbol/ABB\" title=\"ABB LTD.\">ABB</a> <font color=\"red\">-1.3%</font>.<div class=\"tiny-share-widget\" data-id=\"735001\" data-linked=\"After-hours top gainers, as of 2:30 p.m.: TVIX +3.6%. UVXY +3.1%. VXX +1.9%. SE +1.6%. ALXA...\" data-tweet=\"$ENB $TVIX $UVXY - After-hours top gainers, as of 2:30 p.m.: TVIX +3.6%. UVXY +3.1%. VXX +1.9%. SE +1.6%. ALXA +1.6%. After-hours top losers: UGAZ -2.1%. XIV -1.7%. SVXY -1.7%. AIG -1.6%. ABB -1.3%. https://seekingalpha.com/news/735001?source=tweet\" data-url=\"https://seekingalpha.com/news/735001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734891\" data-ts=\"1356373170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLTC\" target=\"_blank\">VLTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motricity (MOTR -33.3%) crashed to a mere $0.43 after disclosing AT&amp;amp;T is terminating a deal...</a></h4>Motricity (MOTR <font color='red'>-33.3%</font>) crashed to a mere $0.43 after disclosing <a href=\"http://biz.yahoo.com/e/121221/motr8-k.html\" target=\"_blank\">AT&amp;T is terminating</a> a deal under which Motricity hosts Ma Bell's MediaNet and ATT.net portals in exchange for monthly fees. The deal accounted for 42% of Motricity's revenue over the first 9 months of 2012. An agreement by which Motricity manages AT&amp;T's AppCenter (far from its most popular data service) remains in place.<div class=\"tiny-share-widget\" data-id=\"734891\" data-linked=\"Motricity (MOTR -33.3%) crashed to a mere $0.43 after disclosing AT&amp;amp;T is terminating a deal...\" data-tweet=\"$VLTC - Motricity (MOTR -33.3%) crashed to a mere $0.43 after disclosing AT&amp;T is terminating a deal under which Motricity hosts Ma Bell&#39;s MediaNet and ATT.net portals in exchange for monthly fees. The deal accounted for 42% of Motricity&#39;s revenue over t... https://seekingalpha.com/news/734891?source=tweet\" data-url=\"https://seekingalpha.com/news/734891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734821\" data-ts=\"1356371206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPTP\" target=\"_blank\">RPTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raptor Pharmaceutical (RPTP -6.5%) slips after it says that the FDA will need an extra three...</a></h4><p>Raptor Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/RPTP\" title=\"Raptor Pharmaceutical Corp.\">RPTP</a> <font color=\"red\">-6.5%</font>) slips after it says that the FDA will need an <a href=\"https://seekingalpha.com/market_currents/post/733631\" target=\"_blank\">extra three months</a> to review the company's Proscysbi drug candidate to treat nephropathic cystinosis, a genetic disease typically affecting young children and infants.</p><div class=\"tiny-share-widget\" data-id=\"734821\" data-linked=\"Raptor Pharmaceutical (RPTP -6.5%) slips after it says that the FDA will need an extra three...\" data-tweet=\"$RPTP - Raptor Pharmaceutical (RPTP -6.5%) slips after it says that the FDA will need an extra three months to review the company&#39;s Proscysbi drug candidate to treat nephropathic cystinosis, a genetic disease typically affecting young children and infants. https://seekingalpha.com/news/734821?source=tweet\" data-url=\"https://seekingalpha.com/news/734821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734791\" data-ts=\"1356370410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina (SINA -2.1%), Baidu (BIDU -1.8%), Sohu (SOHU -2.3%), Youku (YOKU -2.4%), and Renren (RENN...</a></h4><p>Sina (<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"red\">-2.1%</font>), Baidu (<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a> <font color=\"red\">-1.8%</font>), Sohu (<a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Inc.\">SOHU</a> <font color=\"red\">-2.3%</font>), Youku (<a href=\"https://seekingalpha.com/symbol/YOKU\" title=\"Youku Tudou Inc.\">YOKU</a> <font color=\"red\">-2.4%</font>), and Renren (<a href=\"https://seekingalpha.com/symbol/RENN\" title=\"Renren Inc.\">RENN</a> <font color=\"red\">-1.5%</font>) slump following news a People's Congress committee will decide this week on a law requiring Internet users to <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-12-24/china-may-require-web-users-to-register-real-names-xinhua-says.html\">register their real names</a> to have Web access. Sina was required <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/132011\">earlier this year</a> to implement real-name registration for Weibo, but has admitted it <a target=\"_blank\" href=\"http://techcrunch.com/2012/12/23/proposed-chinese-law-may-force-sina-weibo-to-implement-real-name-registration/\">isn't yet able</a> to verify the identities of all posters. The state-run <em>People's Daily</em> has been publishing editorials calling for greater Web regulation.</p><div class=\"tiny-share-widget\" data-id=\"734791\" data-linked=\"Sina (SINA -2.1%), Baidu (BIDU -1.8%), Sohu (SOHU -2.3%), Youku (YOKU -2.4%), and Renren (RENN...\" data-tweet=\"$SINA $SINA $BIDU - Sina (SINA -2.1%), Baidu (BIDU -1.8%), Sohu (SOHU -2.3%), Youku (YOKU -2.4%), and Renren (RENN -1.5%) slump following news a People&#39;s Congress committee will decide this week on a law requiring Internet users to register their real n... https://seekingalpha.com/news/734791?source=tweet\" data-url=\"https://seekingalpha.com/news/734791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734701\" data-ts=\"1356368344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDVN\" target=\"_blank\">MDVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medivation (MDVN -5.7%) spikes lower after a California Superior Court rejected it&#39;s contention...</a></h4><p>Medivation (<a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a> <font color=\"red\">-5.7%</font>) spikes lower after a <a href=\"https://seekingalpha.com/article/1080231-medivation-loses-a-major-patent-dispute-a-blow-to-the-stock\" target=\"_blank\">California Superior Court rejected</a> it's contention that UCLA had violated its agreements with the company by licensing certain compounds to another drug company, Aragon. The court found that the licensing deal did not prohibit the school from granting rights to Aragon for compounds that were discovered prior to those licensed to <a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a>. Aragon is using the compounds to develop a drug, ARN-509, which could compete with Medivation's Xtandi, a prostate cancer treatment already approved by the FDA.</p><div class=\"tiny-share-widget\" data-id=\"734701\" data-linked=\"Medivation (MDVN -5.7%) spikes lower after a California Superior Court rejected it&#39;s contention...\" data-tweet=\"$MDVN - Medivation (MDVN -5.7%) spikes lower after a California Superior Court rejected it&#39;s contention that UCLA had violated its agreements with the company by licensing certain compounds to another drug company, Aragon. The court found that the licen... https://seekingalpha.com/news/734701?source=tweet\" data-url=\"https://seekingalpha.com/news/734701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734601\" data-ts=\"1356365737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATV\" target=\"_blank\">ATV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: ATV +34%. CT +18%. ALIM +12%. CLSN +12%. EJ +11%. EDAP +11%. GSS +11%....</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/ATV' title='Acorn International, Inc.'>ATV</a> <font color=\"green\">+34%</font>. CT <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/EJ' title='E-House &#40;China&#41; Holdings Limited'>EJ</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/GSS' title='Golden Star Resource Corp'>GSS</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color=\"green\">+10%</font>.<br /><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/MHH' title='Mastech Digital, Inc.'>MHH</a> <font color=\"red\">-30%</font>. <a href='https://seekingalpha.com/symbol/TLAB' title='Tellabs, Inc.'>TLAB</a> <font color=\"red\">-27%</font>. <a href='https://seekingalpha.com/symbol/ALXA' title='Alexza Pharmaceuticals, Inc.'>ALXA</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/XRTX' title='Xyratex Ltd.'>XRTX</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/AMPL' title='Ampal - American Israel Corporation'>AMPL</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/SVA' title='Sinovac Biotech, Ltd.'>SVA</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/ISS' title='iSoftStone Holdings Limited'>ISS</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/MITL' title='Mitel Networks Corporation'>MITL</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/RPTP' title='Raptor Pharmaceutical Corp.'>RPTP</a> <font color=\"red\">-8%</font>.<div class=\"tiny-share-widget\" data-id=\"734601\" data-linked=\"Midday top 10 gainers: ATV +34%. CT +18%. ALIM +12%. CLSN +12%. EJ +11%. EDAP +11%. GSS +11%....\" data-tweet=\"$ATV $ATV $BXMT - Midday top 10 gainers: ATV +34%. CT +18%. ALIM +12%. CLSN +12%. EJ +11%. EDAP +11%. GSS +11%. RGLS +10%. AVEO +10%. EGLE +10%.Top 10 Losers: MHH -30%. TLAB -27%. ALXA -14%. XRTX -12%. AMPL -11%. CIG -10%. SVA -9%. ISS -9%. MITL -8%. RP... https://seekingalpha.com/news/734601?source=tweet\" data-url=\"https://seekingalpha.com/news/734601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734531\" data-ts=\"1356363509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVLN\" target=\"_blank\">NVLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegerion Pharmaceuticals (AEGR -4.4%) is getting no love from investors this morning despite...</a></h4><p>Aegerion Pharmaceuticals (AEGR <font color=\"red\">-4.4%</font>) is getting no love from investors this morning despite getting FDA approval for its first approved product, Juxtapid, a treatment for Hypercholesterolemia, which is an inherited disorder that can result in high cholesterol. However, the FDA is requiring a black box warning regarding the drug's liver toxicity, and the company also must certify doctors and receive preauthorization from insurers before patients can receive the drug.</p><div class=\"tiny-share-widget\" data-id=\"734531\" data-linked=\"Aegerion Pharmaceuticals (AEGR -4.4%) is getting no love from investors this morning despite...\" data-tweet=\"$NVLN $NVLNF - Aegerion Pharmaceuticals (AEGR -4.4%) is getting no love from investors this morning despite getting FDA approval for its first approved product, Juxtapid, a treatment for Hypercholesterolemia, which is an inherited disorder that can resu... https://seekingalpha.com/news/734531?source=tweet\" data-url=\"https://seekingalpha.com/news/734531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734491\" data-ts=\"1356362461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu (SVU -7%) spikes lower to erase a late-day rally Friday that saw shares poke their...</a></h4>Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='red'>-7%</font>) spikes lower to erase a late-day rally Friday that saw shares poke their head over $2.80. SA author Saibus Research <a href=\"https://seekingalpha.com/article/1067321-supervalu-s-merger-rumors-overshadowed-analyst-upgrade\" target=\"_blank\">called it</a> last week by noting merger speculation continues to overshadow some decent news on the fundamental front.<div class=\"tiny-share-widget\" data-id=\"734491\" data-linked=\"Supervalu (SVU -7%) spikes lower to erase a late-day rally Friday that saw shares poke their...\" data-tweet=\"$SVU - Supervalu (SVU -7%) spikes lower to erase a late-day rally Friday that saw shares poke their head over $2.80. SA author Saibus Research called it last week by noting merger speculation continues to overshadow some decent news on the fundamental f... https://seekingalpha.com/news/734491?source=tweet\" data-url=\"https://seekingalpha.com/news/734491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734461\" data-ts=\"1356361316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife (HLF -2%) is digging deep to defend itself against the rancorous criticism from hedge...</a></h4><p>Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-2%</font>) is digging deep to defend itself against the <a href=\"https://seekingalpha.com/market_currents/post/733561\" target=\"_blank\">rancorous criticism</a> from hedge fund manager Bill Ackman, who accuses <a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> of being a \"sophisticated pyramid scheme.\". CEO Michael Johnson is calling out to its top institutional investors <a href=\"http://www.latimes.com/business/la-fi-herbalife-response-20121222,0,3110191.story\" target=\"_blank\">to dispute</a> the claim, and has top company officials preparing a point-by-point defense against Ackman's assertions.</p><div class=\"tiny-share-widget\" data-id=\"734461\" data-linked=\"Herbalife (HLF -2%) is digging deep to defend itself against the rancorous criticism from hedge...\" data-tweet=\"$HLF - Herbalife (HLF -2%) is digging deep to defend itself against the rancorous criticism from hedge fund manager Bill Ackman, who accuses HLF of being a &quot;sophisticated pyramid scheme.&quot;. CEO Michael Johnson is calling out to its top institutional inve... https://seekingalpha.com/news/734461?source=tweet\" data-url=\"https://seekingalpha.com/news/734461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734321\" data-ts=\"1356358217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLAB\" target=\"_blank\">TLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers: TLAB -26%. ALXA -11%.</a></h4><b>Premarket </b><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TLAB\" title=\"Tellabs, Inc.\">TLAB</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/ALXA\" title=\"Alexza Pharmaceuticals, Inc.\">ALXA</a> <font color=\"red\">-11%</font>.<div class=\"tiny-share-widget\" data-id=\"734321\" data-linked=\"Premarket Losers: TLAB -26%. ALXA -11%.\" data-tweet=\"$TLAB $TLAB $ALXA - Premarket Losers: TLAB -26%. ALXA -11%. https://seekingalpha.com/news/734321?source=tweet\" data-url=\"https://seekingalpha.com/news/734321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"734191\" data-ts=\"1356355817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/734191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coverage at Herbalife is discontinued at B. Riley, which previously had the shares rated a Buy....</a></h4><p>Coverage at Herbalife is <a href=\"http://www.streetinsider.com/Analyst+Comments/B.+Riley+Drops+Coverage+of+Herbalife+%28HLF%29+Amid+Ack-Attack/7968914.html\" target=\"_blank\">discontinued at B. Riley</a>, which previously had the shares rated a Buy. <a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-1.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"734191\" data-linked=\"Coverage at Herbalife is discontinued at B. Riley, which previously had the shares rated a Buy....\" data-tweet=\"$HLF - Coverage at Herbalife is discontinued at B. Riley, which previously had the shares rated a Buy. HLF -1.5% premarket. https://seekingalpha.com/news/734191?source=tweet\" data-url=\"https://seekingalpha.com/news/734191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":11,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}